Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis: a Randomized Controlled Trial.
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2015
At a glance
- Drugs Denosumab (Primary) ; Bisphosphonates
- Indications Corticosteroid-induced osteoporosis
- Focus Therapeutic Use
- 14 May 2015 Last checked against ClinicalTrials.gov record.
- 29 Oct 2012 Investigational drug identified as Bisphosphonates as reported by ClinicalTrials.gov.
- 29 Oct 2012 Planned End Date changed from 1 Feb 2014 to 1 Apr 2014 as reported by ClinicalTrials.gov.